secwatch.observer — SEC 8-K summary
======================================

Issuer:     MACROGENICS INC (MGNX)
CIK:        0001125345
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0001125345-24-000090
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MacroGenics posts corporate presentation with Phase 2 interim data (TAMARACK trial)
--------------------------------------------------------------------------------

- Corporate presentation posted May 9, 2024; data cut-off April 12, 2024.
- Presentation includes Phase 2 interim data from TAMARACK trial.
- No specific numerical results disclosed in the 8-K excerpt; full presentation on company website.
- Investors should review the complete presentation for material clinical updates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1125345/000112534524000090/0001125345-24-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1125345/000112534524000090/mgnx-20240509.htm
  HTML page:      https://secwatch.observer/filing/0001125345-24-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer